Change search
ReferencesLink to record
Permanent link

Direct link
Is the prognosis in patients with diabetes and heart failure a matter of unsatisfactory management?: An observational study from the Swedish Heart Failure Registry
KTH, School of Architecture and the Built Environment (ABE), Transport Science, Traffic and Logistics. (Centre Safety Research)ORCID iD: 0000-0001-7606-8771
Show others and affiliations
2014 (English)In: European Journal of Heart Failure, ISSN 1388-9842, E-ISSN 1879-0844, Vol. 16, no 4, 409-418 p.Article in journal (Refereed) Published
Abstract [en]

Aims To analyse the long-term outcome, risk factor panorama, and treatment pattern in patients with heart failure (HF) with and without type 2 diabetes (T2DM) from a daily healthcare perspective. Methods and results Patients with (n = 8809) and without (n = 27 465) T2DM included in the Swedish Heart Failure Registry (S-HFR) 2003-2011 due to a physician-based HF diagnosis were prospectively followed for long-term mortality (median follow-up time: 1.9 years, range 0-8.7 years). Left ventricular function expressed as EF did not differ between patients with and without T2DM. Survival was significantly shorter in patients with T2DM, who had a median survival time of 3.5 years compared with 4.6 years (P < 0.0001). In subjects with T2DM. unadjusted and adjusted odds ratios (ORs) for mortality were 1.37 [95% confidence interval (CI) 1.30-1.44) and 1.60 (95% CI 1.50-1.71), and T2DM predicted mortality in all age groups. Ischaemic heart disease was an important predictor for mortality (OR 1.68, 95% CI 1.47-1.94), more abundant in patients with T2DM (59% vs. 45%) among whom only 35% had been subjected to coronary angiography and 32% to revascularization. Evidence-based pharmacological HF treatment was somewhat more extensive in patients with T2DM. Conclusion The combination of T2DM and HF seriously compromises long-term prognosis. Ischaemic heart disease was identified as one major contributor; however, underutilization of available diagnostic and therapeutic facilities for ischaemic heart disease was obvious and may be an important area for future improvement in patients with T2DM and HF.

Place, publisher, year, edition, pages
2014. Vol. 16, no 4, 409-418 p.
Keyword [en]
Heart failure, Diabetes, Mortality, Revascularization, Registry
National Category
Cardiac and Cardiovascular Systems
URN: urn:nbn:se:kth:diva-159404DOI: 10.1002/ejhf.44ISI: 000346700000008OAI: diva2:784445
Swedish Heart Lung Foundation

QC 20150129

Available from: 2015-01-29 Created: 2015-01-29 Last updated: 2015-01-29Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Näsman, Per
By organisation
Traffic and Logistics
In the same journal
European Journal of Heart Failure
Cardiac and Cardiovascular Systems

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 15 hits
ReferencesLink to record
Permanent link

Direct link